After 3 CRLs, FDA approves Outlook's AMD drug Lytenava
After 3 CRLs, FDA approves Outlook's AMD drug Lytenava.
Outlook Therapeutics
Outlook Therapeutics is a ophthalmology company. See today's news for the latest developments.
Company Info
Sector:Ophthalmology
Headquarters:Princeton, New Jersey, USA
Founded:2010
Website:outlooktherapeutics.com/
Upcoming Milestones & Key Dates
2026-07-28
Milestone
Initial profile created
Clinical Development Pipeline
See pipeline
Target: See pipelineRecent News
Leadership Team
See company website
Leadership team
Careers & Job Openings